AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2025
Jun 3, 2025
32227_dirs_2025-06-03_c21e1387-353b-415e-8126-cfc4bce616db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-06-01
Reporting Person: Williams Felicia (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-01 | Common Stock | M | 7160 | — | Acquired | 7160 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-01 | Restricted Stock Unit | $0 | M | 7160 | Disposed | Common Stock (7160) | Direct | |
| 2025-06-01 | Stock Option (Right to Buy) | $7.28 | A | 16107 | Acquired | 2035-06-01 | Common Stock (16107) | Direct |
| 2025-06-01 | Restricted Stock Unit | $0 | A | 23077 | Acquired | Common Stock (23077) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.59 | 2034-06-01 | Common Stock (5430) | 5430 | Direct |
Footnotes
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Once vested, the shares of common stock are not subject to expiration.
More from NEOGENOMICS INC
Board/Management Information
2026
Jun 25
Capital/Financing Update
2026
Jun 22
Capital/Financing Update
2026
Jun 17
Regulatory Filings
2026
Jun 15
Call Transcript
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Call Transcript
2026
May 21
Call Transcript
2026
May 12
Interim / Quarterly Report
2026
Apr 28
Call Transcript
2026
Apr 28